This is a notice of intent to award a sole-source, firm-fixed-price purchase order to QuidelOrtho Sales Company, LLC for a six-month standing order of specific reagents. The performance period is from April 1, 2026, to September 30, 2026. The justification provided is that these reagents are the only ones compatible with the existing Vision analyzer, with no authorized distributors, and using alternates would delay patient care. Capability statements may be submitted via email.